Delivery Order SPE2DB22D2206-SPE2DB25FGS75
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Benlysta 200 mg/ml syringes, with a ceiling value of $6,152.80 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with a completion date of September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Benlysta 200 mg/ml syringes, with a ceiling value of $6,484.10 and firm fixed pricing. This is a non-set-aside competitive award, with an ultimate completion date of December 1, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,152.80 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Benlysta 200 mg/ml syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml syringes valued at $3,076.40. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,242.05 to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Benlysta 200 mg/mL syringes. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of January 6, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $3,076.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml syringes, with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $6,152.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Benlysta 200 mg/ml syringes. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 1, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $3,076.40 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL syringes, with a completion date of May 15, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside structure, to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,152.80 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Benlysta 200 mg/ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the competitive nature of the procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Benlysta 200 mg/ml syringes, with a ceiling value of $3,076.40 and an ultimate completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGS75Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Benlysta 200 mg/ml syringes with a ceiling value of $6,152.80 under firm fixed price terms. This non-set-aside contract is scheduled for completion by May 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order as part of its ongoing support to military and defense medical supply chains. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides a comprehensive global pharmaceutical support mechanism enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs and other federal government healthcare systems worldwide. The contract demonstrates AmerisourceBergen's capability to compete successfully in federal procurement and serve as a key supplier for specialized pharmaceutical products to the Defense Health Agency and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 4/24/25 |